Back to top
more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$8.93 USD

8.93
1,140,640

+0.73 (8.90%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $8.94 +0.01 (0.11%) 7:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (160 out of 244)

Industry: Cosmetics

Zacks News

Zacks Equity Research

Coty's (COTY) Kylie Cosmetics Relaunch to Fortify Business

Coty (COTY) relaunches Kylie Cosmetics, now formulated using clean and vegan ingredients with a revamped packaging. The launch will be available on direct-to-consumer site and at select retailers.

Rajani Lohia headshot

7 Low Price-to-Sales Stocks for Value-Focused Investors

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like NUS, FL, SIG, MET, MT, VSH and SMP are promising picks.

Zacks Equity Research

Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year

Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.

Zacks Equity Research

Solid Skin Care & Online Sales Aid The Estee Lauder Companies (EL)

The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. Also, the company's online operations look impressive.

Vrishali Bagree headshot

4 Cosmetic Stocks to Watch as Consumers Get Ready to Head Out

Focus on strengthening brands through innovation and product launches, along with increased use of cosmetics with people gradually stepping out, bodes well for The Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).

Zacks Equity Research

Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months

Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.

Zacks Equity Research

Helen of Troy (HELE) Spins Off Market Personal Care Business

Helen of Troy (HELE) divests mass market Personal Care business (excluding the Latin America and Caribbean regions) to HRB Brands LLC as part of its strategy to focus on Leadership Brands.

Zacks Equity Research

Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums

Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums

    Vrishali Bagree headshot

    4 Cosmetics Stocks Stealing Attention Despite Industry Woes

    The Zacks Cosmetics industry is battling COVID-19 hurdles like disrupted travel retail and low store traffic. However, high demand for personal care products and focus on innovation bodes well for Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).

    Zacks Equity Research

    Nu Skin (NUS) Up 3.8% Since Last Earnings Report: Can It Continue?

    Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Zacks Equity Research

    Coty (COTY) Poised on Strength in Core Priorities & Partnerships

    Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. Also, it is on track with six priorities aimed at sustainable growth.

    Zacks Equity Research

    Nu Skin (NUS) Looks Buoyant on Product Launches & Online Sales

    Nu Skin (NUS) is benefiting from its focus on innovation and efforts to strengthen sales leader as well as expand customer base.

      Zacks Equity Research

      The Estee Lauder Companies (EL) Looks Poised on Online Sales

      The Estee Lauder Companies (EL) is benefiting from growing online sales. Also, the company's Skin Care portfolio looks impressive.

      Zacks Equity Research

      The Estee Lauder Companies (EL) Ups DECIEM Stake, Boosts Skincare

      The Estee Lauder Companies (EL) now has nearly 76% ownership in DECIEM compared with 29% earlier. This is likely to fuel its skincare business.

      Zacks Equity Research

      Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y

      Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.

      Zacks Equity Research

      Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View

      Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.

      Zacks Equity Research

      Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates

      Nu Skin (NUS) delivered earnings and revenue surprises of 26.39% and 6.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

      Zacks Equity Research

      Nu Skin (NUS) to Report Q1 Earnings: What's in the Cards?

      Efforts to strengthen sales leader and expand customer base along with benefits from product innovations are likely to get reflected in Nu Skin's (NUS) first-quarter 2021 performance.

      Zacks Equity Research

      Nu Skin Enterprises (NUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

      Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Zacks Equity Research

      Inter Parfums (IPAR) Stock Up on Solid Q1 Sales & Raised View

      Inter Parfums (IPAR) sees solid sales growth in the first quarter of 2021, with strength in U.S. and European operations. Further, management raises 2021 view.

      Zacks Equity Research

      Nu Skin (NUS) Looks Radiant on Innovation & Solid Digital Efforts

      Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.

      Zacks Equity Research

      Solid Online Sales Aid Helen of Troy (HELE), Soft Margin a Woe

      Helen of Troy (HELE) is benefiting from solid online operations and Leadership Brands. However, drab operating margin is a headwind.

      Zacks Equity Research

      Nu Skin (NUS) More Than Doubles in a Year: Innovation a Driver

      Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.

      Zacks Equity Research

      Nu Skin (NUS) Down 3.4% Since Last Earnings Report: Can It Rebound?

      Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Zacks Equity Research

      Helen of Troy (HELE) Poised on Leadership Brands, Online Growth

      Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, it is likely to keep gaining from consistent online sales.